Press Releases

01.27.2017

Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the Treatment of Moderate to Severe Active Rheumatoid Arthritis

01.26.2017

Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection

01.19.2017

Milner Therapeutics Institute announces new partnership with US pharmaceutical company Pfizer

01.10.2017

The Scripps Research Institute Signs Collaboration Agreement with Pfizer to Advance DNA-Encoded Library Technology

01.06.2017

Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development

01.05.2017

Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections

01.05.2017

Molecular Stethoscope Completes $8.2M Seed Financing to Advance Circulating Cell-Free RNA Liquid Biopsy Platform; Announces Research Collaboration with Pfizer

01.05.2017

AbCellera Announces Multi-Target Research Collaboration with Pfizer

01.05.2017

Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira®1 (adalimumab)

01.04.2017

Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program

01.03.2017

Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts

12.22.2016

Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca